Search clinical trials for: BRM421

Total 6 results

BRIM Biotechnology Inc.
ORA, Inc.

Completed

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

Dry Eye Syndrome

United States
BRIM Biotechnology Inc.

Completed

Safety and Efficacy of BRM421 for Dry Eye Syndrome

Dry Eye Syndrome

United States
BRIM Biotechnology Inc.

Recruiting

Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.

Dry Eye Disease

United States
BRIM Biotechnology Inc.

Not yet recruiting

Assessment of the Safety and Efficacy of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis

Neurotrophic Keratitis
Odense University Hospital
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); European... and other collaborators

Completed

S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen (BM41)

Allergic Rhinoconjunctivitis | Birch Pollen Allergy

Denmark
University of Southern California

Completed

Rice Bran Supplementation in Treated HIV Infection (BRM4)

Inflammation in HIV Infection

United States

3

Subscribe